Infinity Pharmaceuticals Inc., of Cambridge, Mass., closed its underwritten registered public offering of 6.095 million shares of common stock at $14.50; 795,000 of those shares were sold pursuant to the underwriters' exercise of an overallotment option. Gross proceeds were about $88.4 million.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter